Bonnie F Sloane Selected Research

Cathepsin B

12/2017	Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
3/2015	Cathepsin B-deficient mice as source of monoclonal anti-cathepsin B antibodies.
1/2015	Imaging Sites of Inhibition of Proteolysis in Pathomimetic Human Breast Cancer Cultures by Light-Activated Ruthenium Compound.
12/2014	Cathepsin B contributes to Na+ hyperabsorption in cystic fibrosis airway epithelial cultures.
6/2014	Cathepsin B: multiple roles in cancer.
10/2013	Acid-mediated tumor proteolysis: contribution of cysteine cathepsins.
12/2012	Three-dimensional cultures modeling premalignant progression of human breast epithelial cells: role of cysteine cathepsins.
3/2012	Cathepsin B inhibition limits bone metastasis in breast cancer.
1/2011	Cathepsin B: a potential prognostic marker for inflammatory breast cancer.
1/2011	Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bonnie F Sloane Research Topics

Disease

57	Neoplasms (Cancer) 03/2021 - 03/2002
26	Breast Neoplasms (Breast Cancer) 11/2021 - 08/2002
17	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2003
9	Carcinoma (Carcinomatosis) 08/2015 - 03/2002
8	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2018 - 12/2009
5	Carcinogenesis 12/2017 - 01/2012
5	Prostatic Neoplasms (Prostate Cancer) 03/2009 - 08/2004
4	Inflammatory Breast Neoplasms 11/2015 - 01/2011
3	Glioma (Gliomas) 06/2014 - 09/2002
3	Glioblastoma (Glioblastoma Multiforme) 08/2004 - 09/2002
2	Acidosis 10/2013 - 03/2013
2	Breast Ductal Carcinoma 01/2012 - 12/2009
2	Colonic Neoplasms (Colon Cancer) 02/2008 - 04/2005
2	Colorectal Neoplasms (Colorectal Cancer) 04/2005 - 11/2003
1	Lymphatic Metastasis 11/2021
1	Esophageal Neoplasms (Esophageal Cancer) 11/2015
1	Cystic Fibrosis (Mucoviscidosis) 12/2014
1	Rheumatoid Arthritis 03/2014
1	Infections 03/2014
1	Triple Negative Breast Neoplasms 01/2014
1	Joint Diseases (Joint Disease) 02/2013
1	Hyperplasia 12/2012
1	Neurofibrosarcoma (MPNST) 04/2011
1	Inflammation (Inflammations) 09/2009

Drug/Important Bio-Agent (IBA)

26	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 03/2002
24	Cathepsin BIBA 12/2017 - 07/2002
14	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
11	Cysteine Proteases (Cysteine Protease)IBA 01/2015 - 07/2002
10	CathepsinsIBA 12/2017 - 08/2002
10	CollagenIBA 01/2015 - 08/2002
9	Cysteine (L-Cysteine)FDA Link 12/2017 - 11/2004
7	EnzymesIBA 10/2013 - 01/2003
5	CytokinesIBA 03/2021 - 09/2009
4	Biological ProductsIBA 01/2019 - 03/2002
4	Protease Inhibitors (Protease Inhibitor)IBA 12/2017 - 01/2006
4	Biomarkers (Surrogate Marker)IBA 01/2017 - 02/2008
4	Pharmaceutical PreparationsIBA 02/2013 - 04/2005
3	Conditioned Culture MediaIBA 03/2021 - 12/2009
3	ChemokinesIBA 03/2021 - 01/2014
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2017 - 11/2003
3	Plasminogen Activators (Plasminogen Activator)IBA 01/2017 - 11/2003
3	Interleukin-6 (Interleukin 6)IBA 01/2017 - 01/2010
3	AcidsIBA 10/2013 - 03/2009
3	Messenger RNA (mRNA)IBA 01/2012 - 01/2003
3	Cathepsin KIBA 09/2009 - 08/2006
3	Matrix Metalloproteinases (MMPs)IBA 08/2006 - 04/2005
3	Annexin A2 (Annexin II)IBA 11/2003 - 09/2002
3	procathepsin BIBA 06/2003 - 08/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 04/2004
2	Cystatin AIBA 12/2017 - 03/2012
2	N- (3- propylcarbamoyloxirane- 2- carbonyl)- isoleucyl- prolineIBA 12/2017 - 03/2012
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2017 - 11/2003
2	Talaporfin (talaporfin sodium)IBA 11/2015 - 04/2004
2	Glutamic Acid (Glutamate)FDA Link 01/2014 - 01/2012
2	Bicarbonates (Hydrogen Carbonate)IBA 10/2013 - 03/2009
2	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 03/2013 - 08/2012
2	Glucose (Dextrose)FDA LinkGeneric 03/2013 - 03/2009
2	RNA (Ribonucleic Acid)IBA 01/2012 - 05/2007
2	Protein Isoforms (Isoforms)IBA 01/2012 - 08/2004
2	Caveolin 1IBA 01/2011 - 04/2005
2	Cell Surface ReceptorsIBA 09/2008 - 04/2005
2	Collagen Type IV (Type IV Collagen)IBA 09/2008 - 07/2003
2	Cystatin MIBA 10/2004 - 03/2004
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 01/2018
1	Plasminogen Activator Inhibitor 1IBA 01/2017
1	cabozantinibIBA 02/2016
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2015
1	AntibodiesIBA 03/2015
1	Coloring Agents (Dyes)IBA 01/2015
1	NitrilesIBA 01/2015
1	RutheniumIBA 01/2015
1	Estrogen ReceptorsIBA 01/2014
1	metabotropic glutamate receptor type 1IBA 01/2014
1	Hormones (Hormone)IBA 01/2014
1	Monoclonal AntibodiesIBA 01/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2014
1	ErbB Receptors (EGF Receptor)IBA 01/2014
1	Cathepsin CIBA 10/2013
1	Serine (L-Serine)FDA Link 10/2013
1	HydrogenIBA 03/2013
1	SodiumIBA 03/2013
1	cathepsin SIBA 02/2013
1	JPM 565IBA 03/2012
1	CyclinsIBA 01/2012
1	Aldehyde DehydrogenaseIBA 01/2012
1	Lovastatin (Mevacor)FDA LinkGeneric 04/2011
1	TransferasesIBA 04/2011
1	Biological FactorsIBA 10/2010
1	2,5-dichloro-4-bromophenol (B 2)IBA 01/2010
1	oxidized low density lipoproteinIBA 01/2010
1	CholesterolIBA 01/2010
1	Neutralizing AntibodiesIBA 01/2010
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 12/2009

Therapy/Procedure

10	Therapeutics 11/2021 - 03/2004
2	Injections 03/2021 - 03/2009
1	Precision Medicine 01/2019
1	Photochemotherapy (Photodynamic Therapy) 11/2015
1	Oral Administration 03/2013